Baseline is an independent publication focused on the intersection of business and technology.

Our editors at Baseline work tirelessly to provide our readers with the most relevant and recent business technology information. We work with influencers and industry experts to help you implement technology into your business. 

Every technology solution we recommend has been vetted by our technology.

To maintain objectivity, we don’t accept sponsorships or commissions for promoting specific tech products or free services in exchange for favorable reviews. We provide unbiased opinions and expert insights to inform our audience.

We don't overlook long-term technology trends.

Your technology strategy should serve your business for years to come, which involves ongoing costs and updates. That’s why we don’t just focus on initial implementations. Instead, we gather first-hand data on the long-term expenses associated with maintenance fees, scalability requirements, and potential upgrade costs you can expect.

We are constantly getting better day by day.

We are committed to providing honest assessments – especially if a solution fails to meet expectations. Our publication is an independent technology resource that doesn’t accept payment for positive reviews.

We will tell you when a software isn't what it seems.

We continuously seek ways to enhance our analysis, from developing new benchmarks for software performance to upgrading our software assessment tools. If you’d like to suggest technology solutions or strategies we should evaluate or have any feedback for us, please reach out or join our online forum.

Our latest news and insights.

Autonomic Networks

What are they?Computer networks that manage themselves; sometimes described as “self-managed” or “self-healing.” The term derives from the

Sigma-Aldrich Tweaks Web Formula

If you worked in Sigma-Aldrich’s customer service group three or four years ago, you performed some ugly gyrations

The Bottom Line Per … Jim Bolte

As the vice president of information systems for Toyota’s North American manufacturing operations, Jim Bolte spends his days

Schering-Plough’s Bitter Pill

Schering-Plough, a $9.8 billion drugmaker best known for its Claritin allergy pills, is a chronic violator of Food

By the Numbers: July 2002

E-Markets Get Busy Signs of a World-Class Technology Group Home Security Software Piracy: Tracking the Thieves Customer Focus